SpyGlass Pharma, Inc. Common Stock
SpyGlass Pharma, Inc. Common Stock
- Market cap
- $1.02B
Your view on SGP
Overview
What the company does, where it operates, and who runs it.
About SpyGlass Pharma, Inc. Common Stock
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Patrick H. Mooney
- Headquarters
- 27061 Aliso Creek Road, Aliso Viejo, CA, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Patrick H. Mooney
- Headquarters
- 27061 Aliso Creek Road, Aliso Viejo, CA, US
SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions.
Its flagship investigational product, the Bimatoprost Drug Pad-IOL System (BIM-IOL System), is engineered for implantation during standard cataract removal procedures with the aim of reducing elevated intraocular pressure (IOP) in patients afflicted with either open-angle glaucoma (OAG) or ocular hypertension (OHT).
Co-founded in January 2019 by Malik Y. Kahook and Glenn Sussman, the company maintains its headquarters in Aliso Viejo, CA.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for SpyGlass Pharma, Inc. Common Stock. Starting points for SpyGlass Pharma, Inc. Common Stock: EPS -$2.11, beta -0.89 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for SpyGlass Pharma, Inc. Common Stock. Trailing twelve-month EPS for SpyGlass Pharma, Inc. Common Stock stands at -$2.11. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for SpyGlass Pharma, Inc. Common Stock. SpyGlass Pharma, Inc. Common Stock has reported as a listed company since 2026. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| FAMDFFutura Medical plc | Healthcare | OTC | $6.1M | ||
| FATEFate Therapeutics, Inc. | Healthcare | NASDAQ | $107.1M | ||
| FBIOFortress Biotech, Inc. | Healthcare | NASDAQ | $63.4M | ||
| FBIOPFortress Biotech, Inc. | Healthcare | NASDAQ | $56.0M | ||
| FBLGFibroBiologics, Inc. Common Stock | Healthcare | NASDAQ | $6.3M | ||
| FDMT4D Molecular Therapeutics, Inc. | Healthcare | NASDAQ | $576.8M | ||
| FENCFennec Pharmaceuticals Inc. | Healthcare | NASDAQ | $462.1M | ||
| FGHQFFrontage Holdings Corporation | Healthcare | OTC | $283.9M | ||
| FHTXFoghorn Therapeutics Inc. | Healthcare | NASDAQ | $103.1M | ||
| FLNAFilana Therapeutics, Inc. | Healthcare | NASDAQ | $31.0M | ||
| FNAMEvolutionary Genomics, Inc. | Healthcare | OTC | $1,331 | ||
| FNCHQFinch Therapeutics Group, Inc. | Healthcare | OTC | — | ||
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold SpyGlass Pharma, Inc. Common Stock, and how their positions are changing. At a $1.02B market value, institutional positions materially move SpyGlass Pharma, Inc. Common Stock's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for SpyGlass Pharma, Inc. Common Stock. Coverage tracks SpyGlass Pharma, Inc. Common Stock within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of SpyGlass Pharma, Inc. Common Stock.